InvestorsObserver
×
News Home

Kazia Therapeutics Ltd (KZIA) has fallen 4.63% Monday In Premarket Trading

Monday, July 10, 2023 06:55 AM | InvestorsObserver Analysts

Mentioned in this article

Kazia Therapeutics Ltd (KZIA) has fallen 4.63% Monday In Premarket Trading

Kazia Therapeutics Ltd (KZIA) is down Monday morning, with the stock decreasing -4.63% in pre-market trading to 1.03. KZIA's short-term technical score of 31 indicates that the stock has traded less bullishly over the last month than 69% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, KZIA ranks higher than 50% of stocks. Kazia Therapeutics Ltd has fallen 15.63% over the past month, closing at $1.25 on June 12. During this period of time, the stock fell as low as $1.07 and as high as $1.33. KZIA has an average analyst recommendation of Buy. The company has an average price target of $2.00.

Overall Score - 52
KZIA has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on KZIA!
Kazia Therapeutics Ltd has a Long-Term Technical rank of 52. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 48% of the market scoring higher. In the Biotechnology industry which is number 119 by this metric, KZIA ranks better than 119% of stocks.

Important Dates for Investors in KZIA:

-We do not have a set earnings date for Kazia Therapeutics Ltd at this time. -We do not have a set dividend date for Kazia Therapeutics Ltd at this time. Click Here To Get The Full Report on Kazia Therapeutics Ltd (KZIA)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App